瘢痕疙瘩切除联合辅助治疗:网络Meta分析
配对Meta分析显示切除+1种辅助药物较切除+放疗的复发风险显著更高(OR 3.22,95%CI 1.35-7.67)。网络Meta分析中切除+压力疗法相对未切除的OR为0.18(95%CI 0.01-7.07),但各比较均未达统计学显著性。
要点
- 切除+放疗的复发风险显著低于切除+1种辅助药物(OR 3.22,95%CI 1.35-7.67)。
- 网络Meta分析中切除+压力疗法OR最低(0.18,95%CI 0.01-7.07),但未达显著性。
- 切除+非放疗辅助治疗优于单纯切除,但差异无统计学意义。
核心结论
- 切除+放疗较单纯切除有显著更好的结局。
- 切除+压力疗法优于切除联合其他任何治疗,但未达统计学显著性。
- 切除+非放疗辅助治疗也优于单纯切除,但未达统计学显著性。
研究设计与样本
- 采用配对Meta分析和贝叶斯网络Meta分析,分析复发例数。
主要发现
- 配对Meta分析(6项)显示切除+1种辅助药物较切除+放疗的复发OR为3.22(95%CI 1.35-7.67)。
- 网络Meta分析中相对未切除的复发OR:切除+压力0.18(95%CI 0.01-7.07)。
- 切除+2种辅助药物OR 0.47(95%CI 0.02-12.82);切除+放疗OR 0.39(95%CI 0.04-3.31)。
- 切除+皮肤移植OR 0.58(95%CI 0.00-76.10);切除+1种辅助药物OR 1.76(95%CI 0.17-21.35)。
- 单纯切除OR 2.17(95%CI 0.23-23.95)。
临床怎么用
- 对于瘢痕疙瘩切除术后患者,可优先考虑联合放疗以降低复发风险。
- 压力疗法可能是有益的辅助手段,但证据尚不充分,需结合临床判断。
局限性
- 网络Meta分析中各治疗比较的置信区间宽且均未达统计学显著性。
- 纳入研究数量有限(14项),样本量996例,可能存在异质性和偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Keloid disease treatment continues to be unsatisfactory with high recurrence rates. We evaluated the literature regarding the effectiveness of keloid excision with various adjuvant treatments following surgery and assessed recurrence rates. METHODS: We systematically searched databases through November 2016. We performed pairwise meta-analyses and Bayesian network meta-analyses on the number of recurrences. RESULTS: Following screening, 14 studies including 996 patients with various types of keloids were eligible for inclusion. Patients were categorized based on the receipt of surgery and the type of adjuvant treatment employed afterward. Paired meta-analysis (6 meta-analyses) showed that "excision + 1 adjuvant drug" led to statistically significantly higher odds of recurrence compared to "excision + radiation" (odds ratio [OR], 3.22; 95% confidence interval [CI], 1.35-7.67). Based on the network meta-analyses, the ORs of keloid recurrence following various treatments compared to no excision were as follows: "excision + pressure, 0.18 (95% CI, 0.01-7.07); excision + 2 adjuvants drugs, 0.47 (95% CI, 0.02-12.82); excision + radiation, 0.39 (95% CI, 0.04-3.31); excision + skin grafting, 0.58 (95% CI, 0.00-76.10); excision + 1 adjuvant drug, 1.76 (95% CI, 0.17-21.35); and excision only, 2.17 (95% CI, 0.23-23.95). CONCLUSIONS: According to our results, "excision + radiation" had significantly better outcomes than excision alone. "Excision + pressure" had better outcomes than excision + any other treatment modality, and excision + nonradiation adjuvant therapies were also better than "excision only," although these findings did not reach statistical significance.
引用
- Siotos C, Uzosike AC, Hong H, et al. Keloid Excision and Adjuvant Treatments: A Network Meta-analysis. Ann Plast Surg. 2019. PMID: 31232819. doi:10.1097/SAP.0000000000001951
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。